(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are METABOLIC EXPLORER, NORTHERN DRILLING, and FERMENTALG.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| METABOLIC EXPLORER (METEX.PA) | 0.56 | 27% | 2023-11-08 13:20:19 |
| NORTHERN DRILLING (NODL.OL) | 1.20 | 16.02% | 2023-11-08 12:41:29 |
| FERMENTALG (FALG.PA) | 0.27 | 13.46% | 2023-11-08 13:03:15 |
| GENSIGHT BIOLOGICS (SIGHT.PA) | 0.61 | 12.64% | 2023-11-08 13:04:07 |
| PCI BIOTECH HOLD (PCIB.OL) | 2.54 | 10.22% | 2023-11-08 12:42:02 |
| CNOVA (CNV.PA) | 1.75 | 9.06% | 2023-11-08 13:01:14 |
| LHYFE (LHYFE.PA) | 5.28 | 7.1% | 2023-11-08 13:05:32 |
| BAKKAFROST (BAKKA.OL) | 536.00 | 6.99% | 2023-11-08 12:24:54 |
| CASINO GUICHARD (CO.PA) | 1.06 | 6.47% | 2023-11-08 13:00:51 |
| ARCTICZYMES TECHNO (AZT.OL) | 37.00 | 6.47% | 2023-11-08 12:24:32 |
The three biggest losers today are ANTIN INFRA PARTN, CRAYON GROUP HOLD, and BELUGA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ANTIN INFRA PARTN (ANTIN.PA) | 10.38 | -11.58% | 2023-11-08 12:45:23 |
| CRAYON GROUP HOLD (CRAYN.OL) | 61.75 | -10.96% | 2023-11-08 12:25:25 |
| BELUGA (BELU.BR) | 2.14 | -10.83% | 2023-11-08 12:05:02 |
| ABN AMRO BANK N.V. (ABN.AS) | 11.88 | -9.73% | 2023-11-08 12:00:05 |
| ELECTROMAGNET GEO (EMGS.OL) | 2.04 | -9.33% | 2023-11-08 12:25:37 |
| REINET INVESTMENTS (REINA.AS) | 20.20 | -9.01% | 2023-11-08 12:03:37 |
| PIERRE VAC BSA ACT (VACBS.PA) | 0.11 | -7.44% | 2023-11-08 13:21:20 |
| MAREL (MAREL.AS) | 2.39 | -7.36% | 2023-11-08 12:02:48 |
| IDEX BIOMETRICS (IDEX.OL) | 0.42 | -7.35% | 2023-11-08 12:40:32 |
| LACROIX GROUP (LACR.PA) | 27.00 | -7.22% | 2023-11-08 13:05:19 |
Winners today
1. METABOLIC EXPLORER (METEX.PA)
27% Price Change
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
CAC 40 ended the session with METABOLIC EXPLORER jumping 27% to €0.56 on Wednesday, after four successive sessions in a row of losses. CAC 40 jumped 0.69% to €7,034.16, after three sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.
More news about METABOLIC EXPLORER.
2. NORTHERN DRILLING (NODL.OL)
16.02% Price Change
Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING jumping 16.02% to €1.20 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.73% to €1,273.74.
Earnings Per Share
As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.
More news about NORTHERN DRILLING.
3. FERMENTALG (FALG.PA)
13.46% Price Change
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.
CAC 40 ended the session with FERMENTALG rising 13.46% to €0.27 on Wednesday, after three successive sessions in a row of losses. CAC 40 jumped 0.69% to €7,034.16, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.
Moving Average
FERMENTALG’s worth is way under its 50-day moving average of €0.50 and way under its 200-day moving average of €0.90.
Revenue Growth
Year-on-year quarterly revenue growth declined by 55.4%, now sitting on 4.75M for the twelve trailing months.
More news about FERMENTALG.
4. GENSIGHT BIOLOGICS (SIGHT.PA)
12.64% Price Change
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. The company was incorporated in 2012 and is headquartered in Paris, France.
CAC 40 ended the session with GENSIGHT BIOLOGICS rising 12.64% to €0.61 on Wednesday while CAC 40 jumped 0.69% to €7,034.16.
Earnings Per Share
As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.63.
Yearly Top and Bottom Value
GENSIGHT BIOLOGICS’s stock is valued at €0.61 at 21:40 EST, way below its 52-week high of €3.88 and way higher than its 52-week low of €0.38.
More news about GENSIGHT BIOLOGICS.
5. PCI BIOTECH HOLD (PCIB.OL)
10.22% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 10.22% to €2.54 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.
More news about PCI BIOTECH HOLD.
6. CNOVA (CNV.PA)
9.06% Price Change
Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.
CAC 40 ended the session with CNOVA rising 9.06% to €1.75 on Wednesday while CAC 40 jumped 0.69% to €7,034.16.
Earnings Per Share
As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.
Moving Average
CNOVA’s worth is way under its 50-day moving average of €2.51 and way below its 200-day moving average of €3.22.
More news about CNOVA.
7. LHYFE (LHYFE.PA)
7.1% Price Change
Lhyfe SA, a renewable energy company, designs, installs, and operates green hydrogen production units in France. The company operates 93 projects. It serves local authorities, industries, transport and logistics, and fuel distribution. The company was founded in 2017 and is headquartered in Nantes, France.
CAC 40 ended the session with LHYFE rising 7.1% to €5.28 on Wednesday, after four successive sessions in a row of gains. CAC 40 jumped 0.69% to €7,034.16, after three sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, LHYFE has a trailing twelve months EPS of €-0.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.12%.
Volatility
LHYFE’s last week, last month’s, and last quarter’s current intraday variation average was 18.81%, 0.31%, and 3.85%.
LHYFE’s highest amplitude of average volatility was 18.81% (last week), 7.04% (last month), and 3.85% (last quarter).
More news about LHYFE.
8. BAKKAFROST (BAKKA.OL)
6.99% Price Change
P/F Bakkafrost, together with its subsidiaries, produces and sells salmon products under the Bakkafrost and Havsbrún brands in North America, Western Europe, Eastern Europe, Asia, and internationally. It operates through four segments: Farming FO; Farming SCT; Value Added Products; and Fishmeal, Oil and Fish Feed. The company is involved in the breeding and on-growing of salmon; harvesting, sale, and distribution of salmon; salmon farming, harvest, filleting, sales, and administration; and production of skinless and boneless portions of salmon. It also produces and sells fishmeal, fish oil, and fish feed. In addition, it engages in production of styrofoam boxes, and biogas and fertilizer; and operates trading of fishes, lumpfish farming business, and freight transportation of goods, as well as produce and sell canned fish products. P/F Bakkafrost was founded in 1968 and is headquartered in Glyvrar, Denmark.
Oslo Børs Benchmark Index_GI ended the session with BAKKAFROST jumping 6.99% to €536.00 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, BAKKAFROST has a trailing twelve months EPS of kr11.65.
PE Ratio
BAKKAFROST has a trailing twelve months price to earnings ratio of 46.01. Meaning, the purchaser of the share is investing kr46.01 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.83%.
More news about BAKKAFROST.
9. CASINO GUICHARD (CO.PA)
6.47% Price Change
Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.Casino, Guichard-Perrachon S.A operates as a subsidiary of Rallye SA.
CAC 40 ended the session with CASINO GUICHARD rising 6.47% to €1.06 on Wednesday while CAC 40 rose 0.69% to €7,034.16.
Earnings Per Share
As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-20.53.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.71%.
Yearly Top and Bottom Value
CASINO GUICHARD’s stock is valued at €1.06 at 21:40 EST, way below its 52-week high of €13.26 and way above its 52-week low of €0.82.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5%, now sitting on 33.42B for the twelve trailing months.
Sales Growth
CASINO GUICHARD’s sales growth for the next quarter is negative 11.2%.
Moving Average
CASINO GUICHARD’s worth is way under its 50-day moving average of €1.60 and way under its 200-day moving average of €5.43.
More news about CASINO GUICHARD.
10. ARCTICZYMES TECHNO (AZT.OL)
6.47% Price Change
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Oslo Børs Benchmark Index_GI ended the session with ARCTICZYMES TECHNO jumping 6.47% to €37.00 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74.
Earnings Per Share
As for profitability, ARCTICZYMES TECHNO has a trailing twelve months EPS of kr0.34.
PE Ratio
ARCTICZYMES TECHNO has a trailing twelve months price to earnings ratio of 108.82. Meaning, the purchaser of the share is investing kr108.82 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARCTICZYMES TECHNO’s stock is considered to be oversold (<=20).
Volatility
ARCTICZYMES TECHNO’s last week, last month’s, and last quarter’s current intraday variation average was 6.15%, 1.21%, and 2.55%.
ARCTICZYMES TECHNO’s highest amplitude of average volatility was 7.09% (last week), 3.14% (last month), and 2.55% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 100% and 650%, respectively.
Sales Growth
ARCTICZYMES TECHNO’s sales growth is 5.8% for the present quarter and 45.6% for the next.
More news about ARCTICZYMES TECHNO.
Losers Today
1. ANTIN INFRA PARTN (ANTIN.PA)
-11.58% Price Change
Antin Infrastructure Partners S.A.S. is a private equity firm specializing in infrastructure investments. The firm does not invest in projects which involve technological or commercial risk associated with developing a clientele in a competitive market or invest alongside partners which could represent counterparty risk. It seeks to invest in main infrastructure sectors including transport, energy, environment, and telecommunication. The firm focuses on toll roads, tunnels, highways, tramways, bridges; airports; ports; urban rail, bus lines; car parks in transport; Motorway Service Areas (MSAs); gas storage; LNG terminals; transmission (pipelines, high-voltage electricity transmission); distribution; buildings and public works, generation (non-merchant); water infrastructure (pipelines & sewage units); waste management in energy and environment; and GSM towers; ADSL networks; broadcast networks; cable networks; and satellites in Telecommunication. It typically to invests in non-listed companies based in continental Europe including United Kingdom. It seeks to invest between €200 million ($231.86 million) to €700 million ($811.50 million). The firm may take minority or majority stake allowing representation to the board of directors. It essentially invests in equity and may invest alone or co-invest through a consortium. Antin Infrastructure Partners S.A.S. was founded in 2007 and is based in Paris, France with additional offices in London, United Kingdom, Luxembourg, Luxembourg, Singapore, Singapore and New York, New York.
CAC 40 ended the session with ANTIN INFRA PARTN falling 11.58% to €10.38 on Wednesday while CAC 40 rose 0.69% to €7,034.16.
Earnings Per Share
As for profitability, ANTIN INFRA PARTN has a trailing twelve months EPS of €0.11.
PE Ratio
ANTIN INFRA PARTN has a trailing twelve months price to earnings ratio of 94.36. Meaning, the purchaser of the share is investing €94.36 for every euro of annual earnings.
Volume
Today’s last reported volume for ANTIN INFRA PARTN is 96140 which is 317.78% above its average volume of 23012.
More news about ANTIN INFRA PARTN.
2. CRAYON GROUP HOLD (CRAYN.OL)
-10.96% Price Change
Crayon Group Holding ASA, together with its subsidiaries, operates as an IT advisory company. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, software and cloud advisory service desk, cloud managed services, and support program services; and data platform and AI solutions services. It also offers software and IT asset management services. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with CRAYON GROUP HOLD sliding 10.96% to €61.75 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, CRAYON GROUP HOLD has a trailing twelve months EPS of kr-0.76.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.15%.
Moving Average
CRAYON GROUP HOLD’s value is way below its 50-day moving average of kr105.78 and way under its 200-day moving average of kr98.16.
More news about CRAYON GROUP HOLD.
3. BELUGA (BELU.BR)
-10.83% Price Change
Beluga NV is a private equity and venture capital firm specializing in investments in mid venture, late venture, middle market, and mature companies. It also invests in growth capital, later stages, and buyouts. The firm invests across all sectors in companies based in Belgium with a focus on the Flanders region. It usually invests between €0.25 million ($0.37 million) and €2.5 million ($3.75 million) in the form of a minority stake in both public and private companies. The firm typically invests in companies with enterprise value between €1 million ($1.50 million) and €250 million ($375.7 million), sales values between €0.25 million ($0.37 million) and €500 million ($751.41 million), and EBITDA values between €1 million ($1.50 million) and €100 million ($150.28 million). The firm sources its capital through the stock market. Beluga NV was founded in 1998 and is based in Ternat, Belgium.
BEL 20 ended the session with BELUGA sliding 10.83% to €2.14 on Wednesday, after five successive sessions in a row of losses. BEL 20 fell 0.18% to €3,456.59, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, BELUGA has a trailing twelve months EPS of €0.02.
PE Ratio
BELUGA has a trailing twelve months price to earnings ratio of 107. Meaning, the purchaser of the share is investing €107 for every euro of annual earnings.
Volume
Today’s last reported volume for BELUGA is 1002 which is 1627.59% above its average volume of 58.
More news about BELUGA.
4. ABN AMRO BANK N.V. (ABN.AS)
-9.73% Price Change
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
AEX-Index ended the session with ABN AMRO BANK N.V. dropping 9.73% to €11.88 on Wednesday, following the last session’s upward trend. AEX-Index fell 0.15% to €734.64, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.71.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 4.38. Meaning, the purchaser of the share is investing €4.38 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 21.3% and positive 35.1% for the next.
Volume
Today’s last reported volume for ABN AMRO BANK N.V. is 11775300 which is 285.23% above its average volume of 3056670.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €11.88 at 21:40 EST, way under its 52-week high of €17.00 and way above its 52-week low of €10.40.
More news about ABN AMRO BANK N.V..
5. ELECTROMAGNET GEO (EMGS.OL)
-9.33% Price Change
Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO sliding 9.33% to €2.04 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr0.44.
PE Ratio
ELECTROMAGNET GEO has a trailing twelve months price to earnings ratio of 4.64. Meaning, the purchaser of the share is investing kr4.64 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.52%.
More news about ELECTROMAGNET GEO.
6. REINET INVESTMENTS (REINA.AS)
-9.01% Price Change
Reinet Investments S.C.A. operates as a securitization vehicle in Luxembourg. The company, through its subsidiary, Reinet Fund S.C.A., F.I.S., invests in assets. Reinet Investments Manager S.A. operates as a general partner of Reinet Investments S.C.A. The company was formerly known as Richemont S.A. and changed its name to Reinet Investments S.C.A. in October 2008. Reinet Investments S.C.A. was incorporated in 1979 and is based in Luxembourg City, Luxembourg.
AEX-Index ended the session with REINET INVESTMENTS falling 9.01% to €20.20 on Wednesday, after two consecutive sessions in a row of gains. AEX-Index slid 0.15% to €734.64, following the last session’s upward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, REINET INVESTMENTS has a trailing twelve months EPS of €-0.66.
Volatility
REINET INVESTMENTS’s last week, last month’s, and last quarter’s current intraday variation average was 3.68%, 0.68%, and 4.02%.
REINET INVESTMENTS’s highest amplitude of average volatility was 7.93% (last week), 4.24% (last month), and 4.02% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REINET INVESTMENTS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for REINET INVESTMENTS is 273 which is 7.05% above its average volume of 255.
More news about REINET INVESTMENTS.
7. PIERRE VAC BSA ACT (VACBS.PA)
-7.44% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT falling 7.44% to €0.11 on Wednesday while CAC 40 rose 0.69% to €7,034.16.
Yearly Top and Bottom Value
PIERRE VAC BSA ACT’s stock is valued at €0.11 at 21:40 EST, below its 52-week low of €0.12.
More news about PIERRE VAC BSA ACT.
8. MAREL (MAREL.AS)
-7.36% Price Change
Marel hf. develops, distributes, and sells solutions, software, and services to food processing industries in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. The company's Poultry Processing segment offers integrated systems, software, and services for processing broilers, turkeys, and ducks. Its Meat Processing segment supplies primary, secondary, and further processing equipment, systems, software, and services of pork, beef, veal, and sheep. The company's Fish Processing segment offers equipment, systems, software, and services for farmed and wild salmon and whitefish processing. Its Plant, pet and feed segment provides solutions and services to the pet food, plant-based protein, and aqua feed markets. Marel hf. was founded in 1977 and is based in Garðabær, Iceland.
AEX-Index ended the session with MAREL falling 7.36% to €2.39 on Wednesday while AEX-Index fell 0.15% to €734.64.
Earnings Per Share
As for profitability, MAREL has a trailing twelve months EPS of €0.05.
PE Ratio
MAREL has a trailing twelve months price to earnings ratio of 47.8. Meaning, the purchaser of the share is investing €47.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.87%.
More news about MAREL.
9. IDEX BIOMETRICS (IDEX.OL)
-7.35% Price Change
IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. The company was incorporated in 1996 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS falling 7.35% to €0.42 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.73% to €1,273.74, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-0.22.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -141.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32%, now sitting on 4.7M for the twelve trailing months.
Volatility
IDEX BIOMETRICS’s last week, last month’s, and last quarter’s current intraday variation average was 3.53%, 0.32%, and 3.46%.
IDEX BIOMETRICS’s highest amplitude of average volatility was 5.31% (last week), 4.20% (last month), and 3.46% (last quarter).
Moving Average
IDEX BIOMETRICS’s worth is way below its 50-day moving average of kr0.49 and way below its 200-day moving average of kr0.75.
More news about IDEX BIOMETRICS.
10. LACROIX GROUP (LACR.PA)
-7.22% Price Change
LACROIX Group SA develops, industrializes, produces, and integrates electronic assemblies and subassemblies for the automotive, aeronautics, home automation, industrial, and healthcare sectors. The company operates in three segments: LACROIX Electronics, LACROIX Environment, LACROIX City. It offers connected equipment for managing and coordinating road infrastructures in the areas of street lighting, traffic management, road signs, and V2X; and water and energy facilities, such as smart grids and heating networks. The company operates in France, Germany, the United States, Poland, and Tunisia. LACROIX Group SA was founded in 1936 and is based in Saint-Herblain, France. LACROIX Group SA is a subsidiary of Vinila Investissements.
CAC 40 ended the session with LACROIX GROUP falling 7.22% to €27.00 on Wednesday, after two consecutive sessions in a row of gains. CAC 40 rose 0.69% to €7,034.16, after three sequential sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, LACROIX GROUP has a trailing twelve months EPS of €2.89.
PE Ratio
LACROIX GROUP has a trailing twelve months price to earnings ratio of 9.34. Meaning, the purchaser of the share is investing €9.34 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.71%.
Volatility
LACROIX GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.24%, a negative 0.35%, and a positive 2.07%.
LACROIX GROUP’s highest amplitude of average volatility was 1.68% (last week), 2.04% (last month), and 2.07% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 757.18M for the twelve trailing months.
More news about LACROIX GROUP.
Stay up to date with our winners and losers daily report
